30. mitteilungsblatt nr. 33

30. Mitteilungsblatt Nr. 33 Mitteilungsblatt der Medizinischen Universität Wien Studienjahr 2020/2021 30. Stück; Nr. 33 Bevollmächtigungen

33. Bevollmächtigungen gem. § 27 Abs. 2 UG

30. Stück Mitteilungsblatt, Studienjahr 2020/2021,

ausgegeben am 09.06.2021, Nr. 33

2

Redaktion: Univ.-Prof. Dr. Markus Müller

Druck und Herausgabe: Medizinische Universität Wien

Erscheinung: nach Bedarf; termingebundene Einschaltungen sind mindestens 3 Arbeitstage vor dem gewünschten

Erscheinungsdatum in der Redaktion einzubringen.

33. Bevollmächtigungen gem. § 27 Abs. 2 UG

Gemäß § 27 Abs. 2 UG werden folgende Bevollmächtigungen erteilt:

Auftragsnummer Projekttitel Projektleiter(in) Organisationseinheit

AP13067BGM Kontrollierte Prospektive Randomisierte Studie zur Effizienz der Akupunktur als perioperative Schmerztherapie bei Projekt-Nummer 13067

Hobusch Gerhard Orthopädie und Unfallchirurgie_739

APP34451FW Targeted T Cells Against Oncogenic Calreticulin Mutants

Kralovics Robert Labormedizin_793

The thioredoxin reductase and glutathione reductase system i

Martin Perez Tania Pathophysiologie, Infektiologie und Immunologie_370

FA729A0264 Open-label study to evaluate the pharmacokinetics and safety of VER-01 after single and multiple doses in healthy volunteersv

Wolzt Michael Klinische Pharmakologie_729

FA729A0265 Randomized open-label study to evaluate the pharmacokinetics and safety of VER-01 after single doses with and without meal in healthy volunteers

Wolzt Michael Klinische Pharmakologie_729

Closing the Loop in Hemodialysis: A Precision Medicine Approach

Hecking Manfred Innere Medizin III_716



3





AP21047MWF Einfluss von bakterieller Translokation und dadurch bedingter Inflammation auf Fibrogenese und Fibrolyse bei Patient*innen mit fortgeschrittener Lebererkrankung

Mandorfer Mattias Innere Medizin III_716

Mechanische Herzunterstützung von HFpEF Patient*innen

Zimpfer Daniel Herzchirurgie_732

A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Faricimab in patients with neovascular age-related macular degeneration

Sacu Gülhan Stefan Augenheilkunde und Optometrie_746

FA681A0105 Health risk of emerging concern: PFAS in the urban water cycle

Gundacker Claudia Pathobiochemie und Genetik_306

FA746A0285 A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared with Intravitreal Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Schmidt-Erfurth Ursula

Augenheilkunde und Optometrie_746



4





FA746A0273 A Phase 2, Prospective, Randomized, Double-Masked, Active-Comparator Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Repeated Intravitreal Administration of KSI-301 in Subjects with Neovascular (Wet) Age-Related Macular Degeneration



FA771G0229 A prospective, randomised, Controlled, Open-label, Multicentre phase III study to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET)

Hacker Marcus Radiologie und Nuklearmedizin_771

FA737A0616 EU H2020-SC1-2017-Single-Stage-RTD/Novel Bone Regenration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain

Windhager Reinhard Orthopädie und Unfallchirurgie_739



5





FA716E0993 A randomized, double-blind, dose-ranging, placebo controlled, Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN 74809 in participants with primary sclerosing cholangitis (PSC) and suspected liver fibrosis (INTEGRIS-PSC)

Trauner Michael Innere Medizin III_716

FA716E0992 Bulevirtide treatment efficacy in Austria


FA716D0717 Primary Immunodeficiencies - Austrian Register

Scheinecker Clemens Innere Medizin III_716

FA711C0389 A PHASE 3 MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH PERSISTENT OR CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)”, TP0003 STUDY

Pabinger Ingrid Innere Medizin I_711

FA711B0973 Encorafenib and Cetuximab in patients with metastatic, BRAFV600E mutated, colorectal carcinoma: a multi-centric,

Preusser Matthias Innere Medizin I_711



6





multi-national, prospective, longitudinal, non-interventional study in Germany and Austria. BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment

FA711B0592 Personalized marker-driven early switch to aflibercept on patients with metastatic colorectal cancer (PERMAD-Trial)


FA716E0991 A multicenter observational, phase 4 study to evaluate the safety and tolerability of lenvatinib in patientsw tih advanced or unresectable hepatocellular carcinoma


Efficacy and safety of non-selective beta-adrenergic blockade for treatment of portal hypertension in acute-on-chronic liver failure

Simbrunner Benedikt Michael

Innere Medizin III_716

ÖAW Doc Fellowship 26047

Anisimova Aleksandra

Medizinische Biochemie_305

FA761A1131 A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of Fenebrutinib compared with

Berger Thomas Neurologie_761



7





Teriflunomide in adult patients with relapsing Multiple Sclerosis (FENHANCE)

FA714B2903 Randomized, placebo controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate the efficacy and safety of BAY 2433334 in participants following an acute myocardial infarction PACIFIC-AMI

Hengstenberg Christian

Innere Medizin II_714

Thromboembolic Lesions after Endovascular Coiling of Unruptured Intracranial Aneurysms - A Prospective Study

Dorfer Christian Neurochirurgie_736

Impact of apparent intracellular Helicobacter pylori detected by immunohistochemistry on Treatment failure despite in vitro susceptibility to antibiotics

Starzengruber Peter Labormedizin_793

In vitro Evaluierung antiseptischer Wirkstoffe zur Prävention von fungalen Sekundärinfektionen bei COVID-19

Willinger Birgit Labormedizin_793



8





FA729A1308 An Exploratory Study to Assess the 24-hour Intraocular Pressure (IOP) Lowering Characteristics, Duration of Action and Safety of DE-126 Ophthalmic Solution 0.002% versus Latanoprost Ophthalmic Solution 0.005% in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension

Schmidl Doreen Klinische Pharmakologie_729

FA711C1314 A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL)

Jäger Ulrich Innere Medizin I_711

AP21050MWF Rethinking immunosuppressive induction - a safe path towards costimulation blockade-based maintenance in solid organ transplantation

Muckenhuber Moritz Allgemeinchirurgie_731



9





AP21091MWF Patient*innenzentrierte Ausbildung mithilfe von Echtzeit-Videoaufnahmen auf einer neonatologischen Intensivstation während und nach der COVID-19 Pandemie

Wagner Michael Kinder- und Jugendheilkunde_781

AP21010MWF Medikamenteninteraktionen bei Patient*innen einer Notfallabteilung

Cacioppo Filippo Notfallmedizin_728

FA711B0803 ABCSG 22R Quality of Life, A survey conducted on the quality of life of breast cancer patients registered in ABCSG 22R,


I3Y-MC-JPCW: a randomized, double blind, placebo-controlled phase 3 study of Abemaciclib plus standard adjuvant Endocrine therapy in participants with high-risk, node-positive HR+, HER2+ early breast cancer who have completed adjuvant HER2-targeted therapy


APP34998FW Epigenetic control of the innate immune system

Seiser Christian Anatomie und Zellbiologie_310

FA605A2802 Kamera-basierte Bewegungskorrektur der 7T Gehirnbildgebung und -spektroskopie

Zaitsev Maxim Medizinische Physik und Biomedizinische Technik_340

RORγt and EGR1 – new potential




10





therapy targets to treat cholestatic liver disease?

Untersuchung neuer Therapiekonzepte zur Fibroseregression bei chronischen Lebererkrankungen;

Schwabl Philipp Innere Medizin III_716

FA744A0202 Effects of locally applied glucocorticoids and selective glucocorticoid receptor agonists on the inner ear in an animal model

Arnoldner Christoph Hals-, Nasen- und Ohrenkrankheiten_744

FA660A1401 "EU Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen — U-PGx"

Samwald Matthias Medizinische Statistik, Informatik und Intelligente Systeme_303

FA771G0247 N.c.a. Lu-177 in radiopharmazeutischen Präparationen - operatives Labormanagement.


FA681A0206 Role of Matrix Metalloproteinase-12 in a mouse model of sarcoidosis

Weichhart Thomas Pathobiochemie und Genetik_306

APP34670FW Analysis of missense mutations in organic cation transporter

Sitte Harald Physiologie und Pharmakologie_350



11





FA738A2402 Multinational, , retrospective observational study to evaluate coagulation changes and the influence of antithrombin III treatment in patients with severe COVID-19 infection

Gratz Johannes Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

UE64606003 Überarbeitung der medizinischen Leitlinien für die integrierte Versorgung Demenzerkrankter aus dem Jahr 2011

Rieder Anita Public Health_380

FA714B0528 EU H2020 CResPace

Pavone-Gyöngyösi Mariann


FA781B2204 “MEIN LOGBUCH! – ICH KENNE MICH AUS!” Quality Improvement Projekt - ein Beitrag zur Implementierung und Evaluierung der aktualisierten S3-Leitlinie zur psychosozialen Versorgung in der Pädiatrischen Onkologie und Hämatologie. Entwicklungs- und Pilotphase

Weiler-Wichtl Liesa Kinder- und Jugendheilkunde_781

AP20029BGM Vorstellung einer innovativen, Anker-basierten Rekonstruktionstechnik in der chirurgischen Therapie der A2-Ringband Ruptur

Halat Gabriel Orthopädie und Unfallchirurgie_739

FA605A2301 Coating of Neurovascular Stents

Schima Heinrich Medizinische Physik und Biomedizinische Technik_340



12





AP17947ONB EPITOP-Spezifität von allergen-spezifischen Antikörpern

Bohle Barbara Pathophysiologie, Infektiologie und Immunologie_370

FA781B2802 Combating Viral Susceptibility in Premature Infants

Wisgrill Lukas Kinder- und Jugendheilkunde_781

FA631A0402 AI-driven prediction of novel links from scientific web resources


FA631A0401 Untangling and empowering the web of Artificial Intelligence services


FA729A1204 A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Compare the Efficacy, Safety, and Tolerability of Monoclonal Antibody VIR-7831 Given Intramuscularly for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Non-Hospitalized Patients

Bauer Martin Klinische Pharmakologie_729

FA771G0217 PET/CT and PET/MR imaging of patients with suspected prostate cancer


FA722B1137 A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined with Nivolumab Versus

Höller Christoph Dermatologie_722



13





Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)

FA791A1631 eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib plus Standard Adjuvant Endocrine Therapy in Participants with High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy

Bago-Horvath Zsuzsanna

Pathologie_791

FA791A3309 Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)

Hofstetter Gerda Pathologie_791

FA711B0971 Association of HER2 and HER3 expression with the inflammatory microenvironment composition of breast cancer brain metastases


FA627A0603 Tracking Ewing sarcoma origin by developmental and trans-species genomics

Adameyko Igor Hirnforschung_360



14





ÖAW DOC Fellowship 25951

Bragulat Teixidor Helena


AP17078BGM Prospective Randomized Clinical Trial of Total Thyroidectomy (Tx) versus Thionamides (Anti-Thyroid Drugs) in Patients with Moderate-to-Severe Graves’ Ophthalmopathy - a 1-year Follow-up

Hargitai Lindsay Allgemeinchirurgie_731

Immunregulation durch myeloide Zelltypen

Schabbauer Gernot Physiologie und Pharmakologie_350

AP00986OFF Invasive and non-invasive risk stratification in advanced chronic liver cirrhosis

Semmler Georg Innere Medizin III_716

Live stream of emergency ultrasound to improve diagnostics in prehospital medical care: a feasibility study

Loinger Martina Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

AP18535ONB Proteomic profiling of ETMR tumors

Senfter Daniel Kinder- und Jugendheilkunde_781

Evaluierungs- und Analysestudie im Rahmen des betrieblichen Gesundheitsmanagements bei Deloitte Österreich

Hoffmann Kathryn Public Health_380

FA746A1638 A Phase 3 Multicenter, Randomized, Double Masked, Sham-Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal




15





Administration of Zimura™ (Complement C5 Inhibitor) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

FA729A1402 “PET/MR imaging to asses the role of membrane transporters in pulmonary disposition of inhaled drugs

Langer Claus Oliver Klinische Pharmakologie_729

AP00985OFF Effects of SWI/SNF expression on head and neck squamous cell carcinoma

Schnöll Julia Hals-, Nasen- und Ohrenkrankheiten_744

FA722A1701 Tracking Ewing sarcoma origin by developmental and trans-species genomics

Farlik-Födinger Matthias

Dermatologie_722

AP00984OFF Immunological, genetic and prognostic factors related to outcome in patients with upper gastrointestinal tract cancer

Puhr Hannah Christina

Innere Medizin I_711

Transcranial direct current stimulation (tDCS) and its effect on pathophysiologic mechanisms to improve orchestra musicians´ playing related musculoskeletal disorders (PRMD).

Sterz Fritz Notfallmedizin_728

APP34723FW Role of plasmalogens in ether lipid-associated pathologies

Berger Johannes Hirnforschung_360



16





AP00977OFF Reducing costs of segmentation labeling in cardiac MRI using explainable AI

Agibetov Asan Medizinische Statistik, Informatik und Intelligente Systeme_303

Characterization of the early immunomodulation role of micro-RNAs after lung transplantation

Benazzo Alberto Thoraxchirurgie_733

FA793C0202 SARS-CoV-2 Nachweis mit VERB-Capture im Vergleich zu strandard RT-PCR

Straßl Robert Paul Labormedizin_793

FA744B1203 Kartierung der Kinetik von Zytokin-Reaktionen auf mechanische Stimulation der Nase bei asthmatischen, allergischen und nicht-allergischen Probanden -Eine Pilotstudie

Eckl-Dorna Julia Hals-, Nasen- und Ohrenkrankheiten_744

FA648A1711 The impact of allergen-immunotherapy (AIT) formulations on immunogenicity and efficacy of AIT in a murine model

Untersmayr-Elsenhuber Eva

Pathophysiologie, Infektiologie und Immunologie_370

FA727A0611 PROCESS TRANSFER AND VALIDATION OF APN401

Worel Nina Blutgruppenserologie und Transfusionsmedizin_727

FA681A0206 Role of Matrix Metalloproteinase-12 in a mouse model of sarcoidosis


Evaluation of serologic and molecular markers to optimize risk stratification and

Sperr Wolfgang Reinhard




17





personalized medicine in AML

Cell-free donor DNA as a predictor of rejection and cardiac allograft vasculopathy

Andreas Martin Herzchirurgie_732

FA727A0613 An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases


FA711C0632 JHTB-Studie - A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms


FA751C0664 PIK3CA Registry - A descriptive study of PIK3CA mutations in patients with HR+/Her2- advanced breast cancer

Singer Christian Frauenheilkunde_751

CARTOON: CoronAviRus educaTional prOgram fOr childreN to promote knowledge and hygiene measures and dispel fear during the COVID-19 pandemic

Steinbauer Philipp Kinder- und Jugendheilkunde_781

APW01261FW DK W 1261 Signaling Mechanisms in Cellular Homeostasis

Foisner Roland Medizinische Biochemie_305



18





AP19055BGM Borreliose der Haut - Erforschung der humanen Immunantwort auf eine global zunehmende Erkrankung

Strobl Johanna Dermatologie_722

FA605A1604 Basic applications for total-body PET in oncology

Beyer Thomas Medizinische Physik und Biomedizinische Technik_340

FA605A1603 Dynamic whole-body positron emission tomography for assessing inter-organ signaling

Beyer Thomas Medizinische Physik und Biomedizinische Technik_340

FA714B0381 SELECT, SELExipag in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension

Lang Irene Innere Medizin II_714

FA738C0802 Plasma Pharmacokinetics of Prophylactic Cefazolin Administration for Cardiac Surgery: Comparison of Cardiopulmonary Bypass Priming with Additive Human Albumin 20% versus Pure Crystalloid Priming

Tschernko Edda Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

Prospektive Validierung (Verlaufsbeobachtung) eines Urintests zu frühen Prädikation des klinischen Verlaufs bei Patienten mit SARS-COV-2-Infektion


AP17086BGM Gastric bypass surgery and its impact on human pregnancies: A

Göbl Christian Frauenheilkunde_751



19





longitudinal study to assess implicaton for mothers and offspring

Measuring outcomes of palliative care using PROMs

Fischer Claudia Public Health_380

FA781B2203 Nothing about us without us! PPI paediatric oncology? That's how it works!


APF06104FW Monarchies and Hierarchies in Shaping Chromatin Landcapes

Knapp Sylvia Innere Medizin I_711

FA791A3404 An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib (MK-7902) vs Cabozantinib for Second-line or Third-line Treatment in Participants with Advanced Renal Cell Carcinoma Who Have Progressed After Prior Anti-PD-1/L1 Therapy

Comperat Eva Maria Pathologie_791

AP00979OFF Neoadjuvant therapy of locally advanced difficult to resect basal cell carcinoma (BCC) with Talimogene Laherparepvec (T-VEC)

Ressler Julia Maria Dermatologie_722

FA722C0723 Twinning of research activities for the frontier research in the fields of food, nutrition and

Epstein Michelle Dermatologie_722



20





environmental ‘omics

FA714B4702 Einfluss der Diabetes-Medikation auf den Krankheitsverlauf in Patienten mit Herzinsuffizienz vom HFpEF-Typ

Badr Eslam Roza Innere Medizin II_714

FA774A1001 Venezia Post-Market Clinical Follow-Up Study

Sturdza Alina Emiliana

Strahlentherapie_774

FA726A0601 Risikofaktoren und Arbeitssituation von Gesundheitspersonal in der COVID-19-Epidemie

Jordakieva Galateja Physikalische Medizin, Rehabilitation und Arbeitsmedizin_726

FA746A0267 YOSEMITE: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO6867461 IN PATIENTS WITH DIABETIC MACULAR EDEMA



FA736A0501 Reresearch in 5-ALA Fluorescence in Neurosurgery

Widhalm Georg Neurochirurgie_736

FA731F0509 Invasive Mensch-Maschinen-Schnittstellen / INOPRO

Aszmann Oskar Plastische, Rekonstruktive und Ästhetische Chirurgie_734

UE75106007 Unterstützung Personalkosten Study Nurse: ENGOT-cx12/GCT1015-07 & MK3475-A18/ENGOT-cx11

Polterauer Stephan Frauenheilkunde_751



21





FA714B1520 Assessment of Myocardial Amyloid Deposition, Cardiac Function and Exercise Capacity in Patients with cardiac Transthyretin Amyloidose

Kastner Johannes Innere Medizin II_714

FA722A1601 DAWID Weber Benedikt Dermatologie_722

FA781B1402 Jeffrey Modell Immunodeficiency Center @ MedUni Vienna

Förster-Waldl Elisabeth

Kinder- und Jugendheilkunde_781

FA722A1501 A Phase II, randomized, double-blind, parallel group dose finding study of single oral doses of moxidectin in adults with scabies.

Handisurya Alessandra

Dermatologie_722

FA746A1506 Unrestricted Grant - Single-capture widefield (WF) optical coherence tomography angiography (OCTA) for detection of retinal perfusion and neovascularization in eyes of diabetic patients

Pollreisz Andreas Augenheilkunde und Optometrie_746

FA711C1311 Ibrutinib (Imbruvica®), Bortezomib (Velcade®) s.c., Rituximab, CHOP for the treatment of elderly patients (age 61-80 years) with CD20+ diffuse large B-cell lymphoma, IPI ≥ 2




22





FA722C0438 Randomisierte, multizentrische, kontrollierte, unverblindete Nichtunterlegenheitsstudie der Phase IIIb zur Wirksamkeit, Sicherheit und Verträglichkeit der Umstellung auf lang-wirksames Cabotegravir und Rilpivirin alle 2 Monate von Bictegravir/Emcitritibin/Tenofoviralafenamid fixed-dose Kombination, bei virologisch-supprimierten HIV-1-infizierten Erwachsenen.

Rieger Armin Dermatologie_722



UE78106019 Personalkosten Onko-Team

Peyrl Andreas Kinder- und Jugendheilkunde_781

FA736A0701 Iop. MRT Imaging Rössler Karl Neurochirurgie_736

Eine doppelblinde, randomisierte Phase 3-Studie zum Vergleich der Wirksamkeit und Sicherheit von Luspatercept (ACE-536) gegenüber Placebo bei Studienteilnehmern mit Myeloproliferativer Neoplasma-assoziierter Myelofibrose unter




23





begleitender JAK2-Inhibitortherapie, die eine Transfusion roter Blutzellen benötigen (INDEPENDENCE Studie)

AP15232BGM Abbildungsqualität der Hornhaut nach DMEK versus ultrathin DSEK

Pieh Stefan Augenheilkunde und Optometrie_746

FA711A0311 Methodischen Etablierung moderner intestinaler Mikrobiomanalyse

Watzke Herbert Innere Medizin I_711

FA729A0161 A randomized, placebo-controlled, double-blind, singleascending-dose and multiple-ascending-dose, Phase 1 study to assess the safety and tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of intravenous NTR-441 solution in healthy volunteer adults and COVID-19 patients

Jilma Bernd Klinische Pharmakologie_729

FA781B3201 Dissecting the PathOgenic mechanisms in central nervous system high-grade neuroepithelial tumors with BCOR-alteratioN (CNS HGNET-BCOR)

Gojo Johannes Salomon


FA611A0105 Integrated virtual and traditional anatomy - Excellenz in der

Weninger Wolfgang Anatomie und Zellbiologie_310



24





grenzüberschreitenden medizinischen Ausbildung"

FA791A2111 A randomized, double-blind placebo-controlled, Phase 3 study of Debio 1143 in combination with platinum-based chemotherapy and standard fractionation intensity-modulated radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck, suitable for definitive chemoradiotherapy (TrilynX)

Pammer Johannes Pathologie_791

FA714B5201 Incidence and necessity of ICD therapies (ATP and/or shocks) in the post MADIT-RIT era - a retrospective multicenter analysis

Schukro Christoph Innere Medizin II_714

FA765A0503 Entwicklung eines Online-Selbsthilfeprogrammes zur Suizidprävention bei Kindern und Jugendlichen

Akkaya-Kalayci Türkan

Kinder- und Jugendpsychiatrie_765

FA711A0167 A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory chronic

Watzke Herbert Innere Medizin I_711



25





graft vs host disease after allogenic stem cell transplantation (REACH 3)

FA746A2605 A Non-interventional Multi-center Study Evaluating Clinical Treatment with Idebenone in Patients with Chronic Leber’s Hereditary Optic Neuropathy (LHON)

Pemp Berthold Augenheilkunde und Optometrie_746

FA714B3107 ION - 682884-CS2 Kastner Johannes Innere Medizin II_714

FA744B1202 Moving towards PREcision Medicine In United airways disease: Unravel-ling inflamMatory patterns in asthmatic patients with or without nasal polyps (PREMIUM) – an exploratory pilot study


FA716B0620 Efficacy and safety of once weekly insulin icodec compared to once daily insulin degludec 100 units/mL, both in combination with insulin aspart, in adults with type 1 diabetes.; Protocol ID: NN1436-4625 (the Trial)

Kautzky-Willer Alexandra


FA711C1313 An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 with TL-895 in Subjects with Relapsed/Refracto




26





ry Myelofibrosis and of KRT-232 in Janus-associated Kinase Inhibitor Intolerant Myelofibrosis

FA711C0120 Vonicog alfa (recombinant von Willebrand factor) Treatment Outcomes in von Willebrand Disease in Selected European Countries: a Retrospective Chart Review Study

Kyrle Paul Alexander Innere Medizin I_711

Therakos Centre of Excellence Vienna - Institute Interactive Workshop on GvHD

Wekerle Thomas Allgemeinchirurgie_731

FA781B2201 Mein Logbuch - Ich kenne mich aus!


FA746A1637 A phase IIIb, global, multicenter, randomized, visual assessor−masked study of the efficacy, safety, and pharmacokinetics of a 36-week refill regimen for the port delivery system with Ranibizumab in patients with neovascular age-related macular degeneration


FA716C1010 "EU BEAt-DKD Biomarker Enterprise to Attack DKD to IMI2 JU as part of the Innovative Medicines

Oberbauer Rainer Innere Medizin III_716



27





Initiative 2 Joint Undertaking programme"

AP00827OFF Assessment of antifungal drugs effects on human CD4+ T-cell functions

Schmetterer Klaus Labormedizin_793

FA746A2404 A Phase 2/3 Randomized Study of Rituximabgemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)

Schmidinger Gerald Augenheilkunde und Optometrie_746

FA765A0502 Entwicklung eines Online-Selbsthilfeprogramms zur Suizidprävention bei Kindern und Jugendlichen



FA791A1630 Impassion030- A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING ATEZOLIZUMAB (ANTI-PD-L1 ANTIBODY) IN COMBINATION WITH ADJUVANT ANTHRACYCLINE/Taxane-based CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN PATIENTS WITH OPERABLE TRIPLE NEGATIVE BREAST CANCER


Pathologie_791



28





AP00982OFF ÖGPath Start Up Grant "Evidence of Parvoviridae and SARS-CoV-2 in renal biopsies with tubulointerstital nephritis of unknown origin and patients with SARS-CoV-2 infection"

Nackenhorst Maja Pathologie_791

AP00983OFF The role of APRIL in atherosclerotic cardiovascular disease

Tsiantoulas Dimitrios Labormedizin_793



BacFun Kuchler Karl Medizinische Biochemie_305

FA774A0603 E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

Widder Joachim Radioonkologie_774

FA737A0616 EU H2020-SC1-2017-Single-Stage-RTD/Novel Bone Regenration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain


Entwicklung eines Online-Selbsthilfeprogrammes zur Suizidprävention bei Kindern und Jugendlichen



APP31419FW Knowledgeassisted Visual Analytics

Barisani Talin Pathophysiologie, Infektiologie und Immunologie_370

APKLI861FW COVID-19 und RAS Blockade


API03522FW The role of activin signaling in small cell lung cancer

Dome Balazs Thoraxchirurgie_733



29





FA771G0237 Subleistungsvertrag über die Erbringung von Leistungen im Rahmen einer Studie: A multi-centre, open-label, single-arm, dose-finding phase I/II study to evaluate safety, tolerability, dosing schedule, and preliminary efficacy of carrier-added 4-L-[131I]iodo-phenylalanine (131I-IPA), administered as single or repetitive injections in patients with recurrent glioblastoma multiforme (GBM), concomitantly to 2nd line external radiation therapy (XRT).


APP33867FW Immune responses to meat allergens

Wijnveld Michiel Pathophysiologie, Infektiologie und Immunologie_370

UE64806002 Schimmelpilzallergie in Österreich

Jensen-Jarolim Erika Pathophysiologie, Infektiologie und Immunologie_370

FA648A0617 Development of seed-derived nutraceuticals for the treatment of obesity and related disorders and its combined effects with a high intensity interval training protocol (NUTRISEEDEX)

Pietschmann Peter Pathophysiologie, Infektiologie und Immunologie_370

FA711C0666 A Multicenter, Phase III, Open-label, randomized study in relapsed/refractory patients with




30





Chronic Lymphocytic Leukemia to evaluate the benefit of GDC-0199 (ABT-199) plus Rituximab compared with Bendamustine plus Rituximab

APP34407FW MAZR isoform-specific functions in T cells and beyond.

Ellmeier Wilfried Pathophysiologie, Infektiologie und Immunologie_370

FA791A1145 Ibrutinib (Imbruvica®), Bortezomib (Velcade®) s.c., Rituximab, CHOP for the treatment of elderly patients (age 61-80 years) with CD20+ diffuse large B-cell lymphoma, IPI ≥ 2

Simonitsch-Klupp Ingrid

Pathologie_791

PSMAfore: A phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therapy in the Treatment of Taxane Naïve Men with Progressive Metastatic Castrate Resistant Prostate Cancer

Shariat Shahrokh Urologie_743

FA716C2502 TTV Guide TX Bond Gregor Innere Medizin III_716

APCOV33BGM SARS-CoV-2 bedingte Augenbeteiligung bei Patientinnen mit COVID-19 - Prävalenz und Risiko-Assessment

Lammer Jan Augenheilkunde und Optometrie_746



31





FA716D1901 Disease activity levels and affected domains in psoriatic arthritis patients in clinical routine care – a retrospective cohort study

Kerschbaumer Andreas


FA716E0990 “Post authorization Safety Study Long-Term Safety and Efficacy of Repeat Administration of Darvastrocel in Patients with Chron´s Disease and Complex Perianal Fistula”, Alofisel-4001"


FA714B0379 A Phase 3, Randomized, Double-blind Placebo-controlled Study of Rainepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension


FA714B0378 A Study Evaluating the Long Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-label Extension


FA714B0380 A Study Evaluating the Long-Term Efficacy and Safetiy of Ralinepag in Subjects with PAH via an Open-label Extension




32





FA791A3308 BO41843, A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COM-PARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEP-TOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

Hofstetter Gerda Pathologie_791

FA761A0138 Multicenter, randomized, double-blind, parallel-group extension to study AC-058B201 to investigate the long-term safety, tolerability and efficacy of 10, 20 and 40mg/day ACT-12880, an oral S1P1 receptor agonist, in patients with relapsing-remitting multiple sclerosis

Berger Thomas Neurologie-Klinik_761

FA761A0168 A two-year, double-blind, randomized, multicenter, activecontrolled study to valuate the safety and efficacy of fingolimod administered

Berger Thomas Neurologie-Klinik_761



33





orally once daily versus interferon ß-1a i.m. once weekly in pediatric patients with multiple sclerosis

FA746A1505 A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Faricimab in patients with diabetic macular edema (RHONE-X)

Pollreisz Andreas Augenheilkunde und Optometrie_746

UE78106018 Life happens wherever you are!

Pletschko Thomas Kinder- und Jugendheilkunde_781

FA731T0504 A Phase III Prospective Multicenter Randomized Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow Device plus Standard of Care versus Standard of Care Alone in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Double Lung Transplantation

Jaksch Peter Thoraxchirurgie_733

Entwicklung eines Online-Selbsthilfeprogrammes zur Suizidprävention bei Kindern und Jugendlichen





34





FA641A1105 LS19-019 STAT3 Isoformen in hämatopoetischen Erkrenkungen

Casanova Emilio Physiologie und Pharmakologie_350

FA662A0313 Hämostase Bergmeister Helga Biomedizinische Forschung_308

APKLI917FW Magnetic Resonance Fingerprinting of Patients with Early Stage Osteoarthritis of the Knee Joint at 3 T: Comparison to Conventional T1 and T2 Mapping

Trattnig Siegfried Radiologie und Nuklearmedizin_771

APP31113FW Bacteria-Induced Type 2 Immunity in Host Defense and Disease

Starkl Philipp Innere Medizin I_711

AP13055BGM Zytokinprofile in children with VUR - Zytokinprofil in Kindern mit fieberhaftem Harnwegsinfekt

Müller Leonore Kinder- und Jugendchirurgie_730

FA771G0258 Transferring renal scintigraphy into four dimensions


FA746A1631 A 64-week, two-arm, randomized, double-masked, multicenter, phase IIIb study assessing the efficacy and safety of brolucizumab 6 mg compared to aflibercept 2 mg in a treat-to-control regimen in patients with neovascular agerelated macular degeneration




35





FA714B0377 A prospective, randomized, double-blind, multicenter, placebo-controlled, parallel group, adaptive Phase 3 study with open-label extension to evaluate efficacy and safety of macitentan 75 mg in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension


FA716C0825 A clincal research study entitled "An open-label, controlled, Phase 2 study to evaluate the safety and efficacy of Pegcetacoplan in the treatment of post-translant recurrence of C3G or IC-MPGN "including any subsequent amendments APL2-C3G-204 (Hereinafter known as the "Study")

Sunder-Plaßmann Gere


FA624A0303 European Network Linking Informatics and Genomics of Helper T cells in Tissues

Ellmeier Wilfried Pathophysiologie, Infektiologie und Immunologie_370

FA722A1401 Multicenter, Double Blind, Randomized, Controlled Study of M7824 with Concurrent Chemoradiation Followed by

Ressler Julia Maria Dermatologie_722



36





M7824 versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants with Unresectable Stage III Non-small Cell Lung Cancer.

FA771G0260 A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COM-PARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEP-TOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER


FA771D0526 Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug Coated Balloon versus non-coated Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease (LIMES)

Wolf Florian Radiologie und Nuklearmedizin_771

UE71406007 Drittmittelfinanzierung Study Nurse




37





FA722B2307 Klimawandel Haut Mildner Michael Dermatologie_722

FA711B0707 An Open-Label, Randomized Phase 3 Trial of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma


FA781D0603 Erstellung einer internetbasierten Informationsplattform für Kinderarzneimittel

Male-Dressler Christoph


FA771B0875 A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis (TRANSFORM-2)

Herold Christian Radiologie und Nuklearmedizin_771

FA771B0876 M16-191 - A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib in Subjects with Myelofibrosis (TRANSFORM-1)


FA625A1201 Analyse des Transkiptomprofils und Co-Expressionsnetzwerke von Tumorendothelzellen im

Tolios Alexander Physiologie und Pharmakologie_350



38





Hepatozellulären Karzinom

AP00981OFF Retinomics for precision profiling of coronary heart disease risk



APF06103FW Parsing the pretranscriptonal, transcriptional and posttranscriptional states of interferon- induced genes: chromatin architecture and its regulators.

Farlik-Födinger Matthias

Dermatologie_722

APP34460FW The catecholaminergic system of the human spinal cord

Minassian Karen Medizinische Physik und Biomedizinische Technik_340

AP00980OFF Pathophysiological involvement of exosomes on idiopathic pulmonary fibrosis

Lang-Stöberl Anna Sophie

Pathologie_791

FA711C1312 An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases


FA711B0972 randomized, double-blind, phase-3 study of Tucatinib or placebo in combination with Ado-Trastuzumab Emtansine (T-DM1) for subjects with unresectable locally advanced or metastatic HER2+ breast




39





cancer (HER2CLIMB-02)

FA716D0612 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

Machold Klaus Innere Medizin III_716

FA751D1203 Eisenstatus bei infertilen Frauen und Kontrollgruppe – eine prospektive Fall-Kontrollstudie

Ott Johannes Frauenheilkunde_751

FA781B2103 Life happens wherever you are

Pletschko Thomas Kinder- und Jugendheilkunde_781

FA781B3101 Untersuchung des Einflusses des EGF-Rezeptors auf das Wachstum von Subependymalen Riesenzellastrozytomen

Scholl Theresa Kinder- und Jugendheilkunde_781

FA763C0701 Thiaminsubstitution bei Alkoholabha ̈ngigkeit: Evaluierung aktueller Behandlungsstandards

Amering Michaela Psychiatrie und Psychotherapie_763

FA744A0202 Effects of locally applied glucocorticoids and selective glucocorticoid

Arnoldner Christoph Hals-, Nasen- und Ohrenkrankheiten_744



40





receptor agonists on the inner ear in an animal model

FA714B3701 Multizentrische, prospektive, randomisierte, offene und kontrollierte Phase IV-Studie zu Landiolol in Patienten mit septischen Schock auf Intensivstationen (LANDI-SEP)

Heinz Gottfried Innere Medizin II_714

FA731B2304 pre- versus sub-pectoral implant-based breeast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy

Fitzal Florian Allgemeinchirurgie_731

FA763C0120 EUROPEAN STUDY ON RISK FACTORS FOR VIOLENCE IN MENTAL DISORDERS AND FORENSIC CARE: A MULTICENTRE PROJECT

Wancata Johannes Psychiatrie und Psychotherapie_763

FA648A1710 Computer-based Clustering of Chronic Fatigue Syndrome Patients for Faster Diagnosis and Definition of Suitable Treatment Options - From CFS Patients for CFS Patients

Untersmayr-Elsenhuber Eva


FA771D0525 Eine Phase-I/II-Studie zur Untersuchung von Ibrutinib (Imbruvica®), Bortezomib(Velcade®) s.c., Rituximab, CHOP in der Behandlung

Wolf Florian Radiologie und Nuklearmedizin_771



41





von älteren Patienten (Alter 61-80 Jahre) mit CD20+ diffus großzelligem Lymphom (DLBCL) und IPI ≥ 2

FA648A2201 Nuclei Segmentation

Mahbod Amirreza Pathophysiologie, Infektiologie und Immunologie_370

FA791A2110 Eine randomisierte, doppelblinde, adaptive Phase-II/III-Studie mit GSK3359609 oder Placebo in Kombination mit Pembrolizumab zur Erstlinienbehandlung von PD-L1 positiven rezidivierten oder metastasierten Kopf- und Hals-Plattenepithelkarzinomen (INDUCE-3)

Pammer Johannes Pathologie_791

FA746A3402 FG 9-N Bogunovic Hrvoje Augenheilkunde und Optometrie_746

FA746A0284 FG 9-N Schmidt-Erfurth Ursula


FA729A0161 A randomized, placebo-controlled, double-blind, singleascending-dose and multiple-ascending-dose, Phase 1 study to assess the safety and tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of intravenous NTR-441 solution in healthy volunteer adults and COVID-19 patients




42





FA781B1906 Bereitstellung von Blutzellen von humanen Probanden mit genetischer Tuberöse Sklerose Komplex (TSC) assoziierter Epileptogenese

Feucht Martha Kinder- und Jugendheilkunde_781

FA714B0376 Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients with Pulmonary Arterial Hypertension UNISUS


FA605A2901 Medizintechnik Nohava Lena Medizinische Physik und Biomedizinische Technik_340



FA605A2301 Coating of Neurovascular Stents

Schima Heinrich Medizinische Physik und Biomedizinische Technik_340

AP00886OFF Laserbasierte Methode zur Wiederbesiedelung von dezellularisierter Knorpelmatrix (LaserScaffold) für die Knorpelregeneration

Nürnberger Sylvia Orthopädie und Unfallchirurgie_739

FA791A1144 An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases ATA129-EBV-205


Pathologie_791



43





AP17094BGM The effects of bariatric surgery on brown fat activity and its association with gut microbiota remodeling and bile acid composition

Kiefer Florian Innere Medizin III_716

FA627A0602 Bridging cell states and interactions in sympatho-adrenal development for curing neural crest-tumors - Aufbau der MERFISH Methode


FA738A2801 Comparison of epidural Chloroprocaine 3% and Ropivacaine 0.75% for unplanned Caesarean section in labouring women who have an epidural catheter in situ

Marhofer Daniela Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

FA729A0162 A single-center ex-vivo study to assess the effect of abelacimab for preventing contact surface induced thrombosis


FA729A1046 Comparison of two different methods of sample self-collection and health- care- worker collected nasopharyngeal swab for the detection of SARS-CoV-2 via an antigen rapid assay against gold standard PCR

Zeitlinger Markus Klinische Pharmakologie_729

FA738A0809 European Health Data and Evidence Network

Kimberger Oliver Anästhesie, Allgemeine



44





Intensivmedizin und Schmerztherapie_738

API03243FW Oxytocin-like neuropeptide signaling in locusts

Gruber Christian Physiologie und Pharmakologie_350

FA771G0259 Combination therapy in combating cholangiocarcinoma


FA711C1310 Österreichisches Brentuximab Vedotin Register


FA690A0702 Development of Robust Influenza Vaccine Effectiveness

Redlberger-Fritz Monika

Virologie_307

FA646A0901 2020 Estimation of Girls at Risk of FGM

Jirovsky-Platter Elena Public Health_380

FA627A0402 4BL cells: novel mediators of tissue damage in relapsing and progressive multiple sclerosis

Bauer Jan Hirnforschung_360

FA744B1103 A randomized, double-blind placebo-controlled, Phase 3 study of Debio 1143 in combination with platinum-based chemotherapy and standard fractionation intensity-modulated radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck, suitable for definitive chemoradiotherap

Brunner Markus Hals-, Nasen- und Ohrenkrankheiten_744



45





y (TrilynX).” Debio 1143-SCCHN-301

FA714C0708 Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug Coated Balloon versus non-coated Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease (LIMES)

Schlager Oliver Innere Medizin II_714

FA646A0702 Cancer prevention and early detection among the homeless population in Europe: Co-adapting and implementing the Health Navigator Model

Grabovac Igor Public Health_380

FA722C0725 An innovative analytical platform to investigate the effect and toxicity of micro and nano plastics combined with environment contaminations on the risk of allergic disease in preclinical and clinical

Epstein Michelle Dermatologie_722



46





FA716C0914 A prospective, observational long-term follow-up trial of kidney transplant patients treated with imlifidase or plasma exchange after an active/chronic active Antibody-Mediated Rejection episode

Böhmig Georg Innere Medizin III_716

FA712A0511 GPC3/CpG as HCC Treatment

Sibilia Maria Innere Medizin I_711

FA647A0803 Homo sanus in caeli sano - Ein gesunder Mensch in einem gesunden Klima. Potenzielle Synergien zwischen Gesundheitspolitik und Klimapolitik

Haluza Daniela Public Health_380

FA605A1906 TEXtile integrated HYbrid Printed Electronics

Moscato Francesco Medizinische Physik und Biomedizinische Technik_340

FA732A0103 The Use of the EXCOR Active Driving Unit for Mobilization of Pediatric Patients with Ventricular Assist Device Support- E-Motion


FA791A0723 SOPHiA aims to develop a bundle solution product (BS) composed of an analytical algorithm and an associated capture kit, to assess Homologous Recombination repair Deficiency (HRD) score using targeted sequencing on HR genes with low pass WGS to

Müllauer Leonhard Pathologie_791



47





calculate HRD score, including to be used to classify tumour suitability for PARP inhibitor or platinum based chemotherapy treatment.

APP34023FW Granulomas and disease in sarcoidosis


APP34136FW Control of multipotency in neural crest in health and disease


FA729A0160 A Phase 2, Single-Center, Open-Label, Repeat-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of Intravenous ANX005 in Participants with Primary Cold Agglutinin Disease


FA711B0910 A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)




48





FA648A0310 The library of allergenic molecules

Valenta Rudolf Pathophysiologie, Infektiologie und Immunologie_370

FA793A0337 Baxalta field study Quehenberger Peter Labormedizin_793

FA751C0670 Neratinib in patients with HER2+ breast cancer: a multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria


FA716E0989 Diagnoseerstellung und Risikostratifizierung von Lebererkrankungen mittels Deep Learning anhand von klinischen Routinedaten


FA751C0648 Real World Evidence Collection Of Effectiveness Data Of First Line Ribociclib In Combination With Endocrine Therapy In Hormone-Receptor Positive (HR+), HER2-Negative (HER2-) Advanced Breast Cancer (aBC) In Austria – REACH AUT


FA791A2603 GO41892: A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL, CON-TROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKI-NETICS OF

Geleff Silvana Pathologie_791



49





ATEZOLIZUMAB GIVEN IN COMBINATION WITH CABOZANTINIB VER-SUS DOCETAXEL MONOTHERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER PREVIOUSLY TREATED WITH AN ANTI-PD-L1/PD-1 ANTI-BODY AND PLATINUM-CONTAINING CHEMOTHERAPY

FA791A1629 Impassion030- A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING ATEZOLIZUMAB (ANTI-PD-L1 ANTIBODY) IN COMBINATION WITH ADJUVANT ANTHRACYCLINE/Taxane-based CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN PATIENTS WITH OPERABLE TRIPLE NEGATIVE BREAST CANCER


Pathologie_791

FA731A0106 Characterization myeloid cells in CRC including peritoneal metastasis and development of autologous organotypic assays

Oehler Rudolf Allgemeinchirurgie_731

FA632A0403 Praktikum Statistik Frommlet Florian Medizinische Statistik, Informatik und Intelligente Systeme_303



50





FA761A1130 A phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis " EFC16645 -HERCULES

Berger Thomas Neurologie_761

AP17103BGM Vitrifikation von humanem Ovargewebe - eine prospektive Pilotstudie

Marschalek Julian Frauenheilkunde_751

FA714B5101 Iron and chronic thrombosis

Campean Ioana-Alexandra


FA791A3602 “Double-blind, randomised, placebo-controlled, phase IIb trial on the efficacy and safety of norursodeoxycholic acid tablets in patients with non-alcoholic steatohepatitis (NASH)”

Herac Merima Pathologie_791

AP00978OFF GTH Early Career Research Grant 2021

Moik Florian Innere Medizin I_711

FA791A1142 A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis (TRANSFORM-2)


Pathologie_791



51





FA791A1143 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib in Subjects with Myelofibrosis (TRANSFORM-1)


Pathologie_791



FA751C0669 A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib plus Standard Adjuvant Endocrine Therapy in Participants with High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy


FA751C0702 Early Detection of Ovarian Cancer using Uterine Lavage and Duplex Sequencing

Speiser Paul Frauenheilkunde_751

FA711B0970 a phase-III randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy and safety of GDC-9545




52





combined with Palbociclib compared with Letrozole combined with Palbociclib in patients with Estrogen receptor-positive, HER2-negative, locally advanced or metastatic breast cancer

FA732A0102 Registry to Assess the Saftey and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/absence of the Right Heart-RegiVe Studie


FA781B2706 Internationale Medical VR Kooperation

Wagner Michael Kinder- und Jugendheilkunde_781

FA729A1039 Investigation of liquor penetration of ceftazidime/avibactam, ceftaroline and isavuconazole in healthy volunteers and exploration of liquor levels in patients


FA729A1038 Target attainment of Ceftazidime-avibactam (Zavicefta®) in bone of patients undergoing Cardiac Surgery


FA729A1037 Investigation of ELF and soft tissue penetration of isavuconazole in healthy volunteers and exploration of protein binding




53





and intracellular accumulation in-vivo

FA793A2401 Identification of clinical, genetic and immunosuppressive factors predisposing to non-melanoma skin cancer (NMSC) in immunosuppressed organ transplant recipients compared to controls – a case-control study

Sunder-Plaßmann Raute

Labormedizin_793

AP17001BGM Individueller Komplotyp in Patienten mit Komplement-mediierter Throbotischer Mikroangiopathie, sekundärer thrombotischer Mikroangiopathie und gesunden Kontrollen

Aigner Christof Innere Medizin III_716

SOLARIO - Short or Long Antibiotic Regimes In Orthopaedics


FA746A0283 A MULTICENTER, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION





54





FA771B0874 “Post authorization Safety Study Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients with Crohn´s Disease and Complex Perianal Fistula”, Alofisel-4001


FA722A0506 Efficacy and safety comparison of brodalumab versus guselkumab in adult subjects with moderate-to-severe plaque psoriasis and inadequate response to ustekinumab; COBRA.

Jonak Constanze Dermatologie_722

FA602A0112 Learning In ValuE based health care project

Stamm Tanja Medizinische Statistik, Informatik und Intelligente Systeme_303

FA729A0156 Safety, tolerability and activity of BIVV009 in healthy volunteers and patients with complement-mediated disorders. A simple/multiple ascending dose phase 1 study


FA727A0609 Phase I, open Label, multicenter, dose escalation 2055/20and DLBCL


AP20080BGM Das Wiener Psychose Netzwerk (WPN) - Plattform für die Integration von klinischer Versorgung und

Willeit Matthäus Psychiatrie und Psychotherapie_763



55





akademischer Forschung im Bereich psychotischer Erkrankungen

AP17082BGM Oral Sodium Bicarbonate Supplementation in Patients with Chronic Metabolic Acidosis and Kidney Disease (SoBic-Study)

Gaggl Martina Innere Medizin III_716

FA714C0606 Eine offene Studie zur Untersuchung der Langzeitsicherheit und Wirksamkeit von Evinacumab bei Patienten mit homozygoter familiärer Hypercholesterinämie

Willfort-Ehringer Andrea


FA618A0209 Understanding the molecular role of a CGT clade-specific histone H3 variant in the pathobiology of the human fungal pathogen Candida albicans

Kuchler Karl Medizinische Biochemie_305

FA738C0901 Observational cohort study to characterise the current use of parenteral nutrition and clinical outcomes in adult critically ill patients hospitalised in intensive care units in Europe

Zapletal Bernhard Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

FA738A2301 Acute Kidney Injury in Post-operative ICU

Faybik Peter Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738



56





FA648A1020 BY: Deep learning for improved nuclei Segmentation and knowledge Transfer methods in microscopic images

Ellinger Isabella Pathophysiologie, Infektiologie und Immunologie_370

FA722C1601 "Deciphering genomic aberrations in rare skin cancers to find mechanism-based treatment strategies"

Wiesner Thomas Dermatologie_722

FA623A0222 Observer blinded, randomized trial to evaluate safety and immunogenicity of a novel vaccine formulation MV-ZIKA-RSP

Wiedermann-Schmidt Ursula


FA690A0104 Epidemiologische Veränderung der FSME in Österreich

Stiasny Karin Virologie_307

FA714B4501 Eine multizentrische, randomisierte, doppelblinde, double-dummy, aktiv gegen Vergleichsmedikation kontrollierte, parallelgruppen, Dosisfindungs-Phase 2-Studie um die Sicherheit von FXIa Inhibitor BAY 2433334 im Vergleich zu Apixaban bei Patienten mit Vorhofflimmern zu vergleichen.: Pacific-AF Study

Schönbauer Robert Innere Medizin II_714

FA684A0103 Identification of readouts for the evaluation of treatment strategies in RCDP

Berger Johannes Hirnforschung_360



57





APCOV10BGM Screening of inflammatory biomarkers to assess treatment options for severely symptomatic COVID-19 patients

Kovarik Johannes Innere Medizin III_716

FA602A0107 Deploying AAL Packages at Scale

Stamm Tanja Medizinische Statistik, Informatik und Intelligente Systeme_303

AP20032BGM VOICE Studie - PatientInnen eine Stimme geben: Wünsche und Bedürfnisse der österreichischen Bevölkerung zur hausärztlichen Versorgung in Österreich

Hoffmann Kathryn Public Health_380

APCOV50BGM Einfluss der COVID-19-Pandemie auf das Leben und die Behandlung von Personen mit Psychose aus dem schizophrenen Formenkreis: eine qualitative Studie

Fellinger Matthäus Psychiatrie und Psychotherapie_763

AP00947OFF Circulating Tumour Cells: Companion Diagnostics in Platinum-Sensitive Ovarian Cancer?

Aust Stefanie Frauenheilkunde_751

FA728A0605 COOL-AMI EU PIVOTAL TRIAL: A MULTICENTER, PROSPECTIVE, RANDOMIZED-CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFECTIVENESS OF COOLING AS AN ADJUNCTIVE THERAPY TO PERCUTANEOUS

Sterz Fritz Notfallmedizin_728



58





INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Kooperationsvertrag "Weiterentwicklung Kinderzahnheilkunde" abgeschlossen zwischen der Medizinischen Universität Wien und der Deutschen Gesellschaft für Kinderzahnheilkunde

Bekes Katrin Universitätszahnklinik Wien GmbH_991

Factor XA Inhibition in RENal patients with non-valvular atrial fibrillation Observational study

Bergler-Klein Jutta Innere Medizin II_714

AP00846OFF Neurosteroide als neue Marker in der Diagnostik der Präeklampsie sowie in der Prognose des neonatalen Outcomes?

Windsperger Karin Frauenheilkunde_751

APP29251FW PDGFRB function in lymphoma progression

Kenner Lukas Pathologie_791

Repuls 7 PDI-Strahler zur photodynamischen Inaktivierung von Viren & Bakterien im Mund-Rachenraum

Schicho Kurt Mund-, Kiefer- und Gesichtschirurgie_742

AP19026BGM Sprunggelenke – strukturelle Veränderungen in unterschiedlichen Gelenkspositionen

Hirtler Lena Anatomie und Zellbiologie_310



59





und bei nicht-invasiver Distraktion

AP20016BGM Characterisation of the nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease (N-ERD) – a pilot study


AP00931OFF Crosstalk between YB-1 and microRNAs: a vicious cycle in malignant pleural mesothelioma?

Schelch Karin Innere Medizin I_711

AP00861OFF Impact of local and systemic treatments on the inflammatory microenvironment composition in brain metastases

Bergmeister-Berghoff Anna Sophie


AP15005BGM Verbesserung der ÄrztInnen-PatientInnen-Kommunikation: Sexuelle Dysfunktion bei PatientInnen mit Adrenogenitalem Syndrom - Einfluss von Genotyp, Gender und Migrationshintergrund auf Information und Betreuungsqualität

Bayerle-Eder Michaela Innere Medizin III_716

FA727A0609 Phase I, open Label, multicenter, dose escalation 2055/20and DLBCL


APP31255FW Pharmacological rescue of creatine Transporter-1Variants

Sucic Sonja Physiologie und Pharmakologie_350



60





AP15144BGM Computergestützte Ebenenkontrolle in der 2D-Säuglingssonographie

Kolb Alexander Orthopädie und Unfallchirurgie_739

FA722C0904 Unraveling the mechanisms of octenidine dihydrochloride efficacy on human skin.

Elbe-Bürger Adelheid Dermatologie_722

FA711B0933 A phase 1/2, open-label study, evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of AMG 510 Monotherapy in subjects with advanced solid tumors with KRAS p.G12C mutation and AMG 510 Combination Therapy in subjects with advanced NSCLC with KRAS p.G12C mutation


FA711B0599 A randomised phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancer (SGCs)


FA711A0168 Vertrag über die Erbringung von Laborleistungen im Rahmen der klinischen Arzneimittelstudie




61





“Personalized marker-driven early switch to aflibercept on patients with metastatic colorectal cancer (PERMAD-Trial)”

FA711C1080 Evaluation of certain data regarding the relative efficacy of two interferon 2 alpha for the treatment of polycythemia vera


FA711C0653 "REGISTRY TO RECLASSIFY early Thrombozythemia, early Myelofibrosis and Polycythemia Vera sample Studiennummer: CINC424XAT01T"


FA711C0644 MPN Mutational Analysis to unravel molecular patterns in early stages of disease, during treatment (incl. Ruxolitinib) and leukemic transformation


APW01207FW Doktoratskolleg - RNA Biologie

Leodolter-Barta Andrea


APP31599FW Exploring Ligand selectivity in monoamine transporters

Sandtner Walter Physiologie und Pharmakologie_350

APP30972FW NK cell-mediated antigen specific memory in human

Stary Georg Dermatologie_722

APP30105FW Dissecting the Role of Fibroblast Growth Factor Receptor 4 in Human Glioblastoma/Gliosarcoma

Berger Walter Innere Medizin I_711



62





APP29948FW Loss of the CaSR in colorectal tumourigenesis

Kallay Enikö Pathophysiologie, Infektiologie und Immunologie_370

API03334FW SCI-induced systemic maladaptive immune response and autoimmunity to CNS (SILENCE)

Höftberger Romana Neurologie-Institut_796

API03073FW Information-Theoretic Perspective on Complex Systems

Thurner Stefan Medizinische Statistik, Informatik und Intelligente Systeme_303

Markus Müller

Rektor

30. mitteilungsblatt nr. 33

Documents